Related Experiment Video
Updated: May 5, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells
Shuai Gao1, Chen-Lin Hsieh, Jun Zhou
1Department of Biological Sciences, University of Toledo, Toledo, Ohio, United States of America.
Abstract:
The Zinc Finger (ZNF) 280B protein was identified as an unexpected target of an shRNA designed for sGCα1. Further analysis showed that these two proteins are connected in another way, with 280B up-regulation of sGCα1 expression. Knock-down and over-expression experiments showed that 280B serves pro-growth and pro-survival functions in prostate cancer. Surprisingly however, these pro-cancer functions of 280B are not mediated by sGCα1, which itself has similar functions in prostate cancer, but by down-regulated p53. The p53 protein is a second target of 280B in prostate cancer, but unlike sGCα1, p53 is down-regulated by 280B. 280B induces p53 nuclear export, leading to subsequent proteasomal degradation. The protein responsible for p53 regulation by 280B is Mdm2, the E3 ubiquitin ligase that promotes p53 degradation by inducing its nuclear export. We show here that 280B up-regulates expression of Mdm2 in prostate cancer cells, and this regulation is via the Mdm2 promoter. To demonstrate an in vivo relevance to this interaction, expression studies show that 280B protein levels are up-regulated in prostate cancer and these levels correspond to reduced levels of p53. Thus, by enhancing the expression of Mdm2, the uncharacterized 280B protein provides a novel mechanism of p53 suppression in prostate cancer.
Insights
Zinc Finger 280B (ZNF280B) promotes prostate cancer growth by down-regulating p53. ZNF280B increases Mdm2 expression, leading to p53 degradation and supporting cancer cell survival.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Soluble guanylate cyclase alpha 1 (sGCα1) is implicated in prostate cancer.
- Zinc Finger (ZNF) 280B is an uncharacterized protein with potential roles in cancer.
Purpose of the Study:
- To investigate the function of ZNF280B in prostate cancer.
- To elucidate the molecular mechanisms by which ZNF280B affects cancer progression.
Main Methods:
- Knock-down and over-expression experiments were used to assess ZNF280B function.
- Western blotting and quantitative PCR were employed to analyze protein and gene expression.
- Immunofluorescence was utilized to track p53 localization.
- Luciferase reporter assays were performed to study Mdm2 promoter activity.
Main Results:
- ZNF280B promotes prostate cancer cell growth and survival.
- ZNF280B up-regulates sGCα1 expression but does not mediate its own pro-cancer effects.
- ZNF280B down-regulates p53 by inducing its nuclear export and proteasomal degradation.
- ZNF280B up-regulates Mdm2 expression via the Mdm2 promoter.
- ZNF280B levels are elevated in prostate cancer correlating with reduced p53 levels.
Conclusions:
- ZNF280B exerts pro-growth and pro-survival functions in prostate cancer.
- ZNF280B suppresses p53 by increasing Mdm2 expression, representing a novel mechanism of p53 inactivation in prostate cancer.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

